EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hereditary pulmonary arterial hypertension burden in pediatrics: A single referral center experience

Maki Ishizuka, Wenxin Zou, Elise Whalen, Erin Ely, Ryan D Coleman, Dolores H Lopez-Terrada, Daniel J Penny, Yuxin Fan, Nidhy P Varghese

Frontiers in Pediatrics · 29.03.2023 · 11

DOI: 10.3389/fped.2023.1050706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 29.03.2023. Verfasst von Maki Ishizuka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Critical Care, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hereditary pulmonary arterial hypertension (HPAH) is a rare yet serious type of pulmonary arterial hypertension (PAH). The burden in the pediatric population remains high yet underreported. The objective of this study is to describe the distribution of mutations found on targeted PAH panel testing at a large pediatric referral center.

Methods

Children with PAH panel administered by the John Welsh Cardiovascular Diagnostic Laboratory at Texas Children's Hospital and Baylor College of Medicine in Houston, Texas between October 2012 to August 2021 were included into this study. Medical records were retrospectively reviewed for clinical correlation.

Results

Sixty-six children with PAH underwent PAH genetic testing. Among those, 9 (14%) children were found to have pathogenic mutations, 16 (24%) children with variant of unknown significance and 41 (62%) children with polymorphism (classified as likely benign and benign). BMPR2 mutation was the most common pathogenic mutation, seen in 6 of the 9 children with detected mutations. Hemodynamic studies showed higher pulmonary vascular resistance among those with pathogenic mutations than those without (17.4 vs. 4.6 Wood units). All children with pathogenic mutations had severe PAH requiring triple therapy. There were tendencies for higher lung transplantation rate but lower mortality among those with pathogenic mutations.

Conclusions

Abnormalities on genetic testing are not uncommon among children with PAH, although majority are of unclear significance. However, children with pathogenic mutations tended to present with more severe PAH requiring aggressive medical and surgical therapies. Genetic testing should be routinely considered due to consequences for treatment and prognostic implications. Larger scale population studies and registries are warranted to characterize the burden of HPAH in the pediatric population specifically.

Schlagwörter

Stichwörter der Autor:innen

genetichereditarypediatrcispulmonary arterial hypertensiontertiary referral center

Autor:innen und Institutionen

  • Department of Pediatrics, Critical Care, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
  • Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States.
  • John Welsh Cardiovascular Diagnostic Laboratory, Division of Genomic Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX, United States.
  • Department of Pediatrics, Pulmonology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
  • Division of Genomic Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX, United States.
  • Department of Pediatrics, Cardiology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.

Zitieren

APA

Ishizuka, M., Zou, W., Whalen, E., Ely, E., Coleman, R. D., Lopez-Terrada, D. H., Penny, D. J., Fan, Y., & Varghese, N. P. (2023). Hereditary pulmonary arterial hypertension burden in pediatrics: A single referral center experience. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1050706

Vancouver

Ishizuka M, Zou W, Whalen E, Ely E, Coleman RD, Lopez-Terrada DH, et al. Hereditary pulmonary arterial hypertension burden in pediatrics: A single referral center experience. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1050706

BibTeX
@article{Ishizuka2023,
  author = {Ishizuka, Maki and Zou, Wenxin and Whalen, Elise and Ely, Erin and Coleman, Ryan D and Lopez-Terrada, Dolores H and Penny, Daniel J and Fan, Yuxin and Varghese, Nidhy P},
  title = {Hereditary pulmonary arterial hypertension burden in pediatrics: A single referral center experience},
  journal = {Frontiers in Pediatrics},
  year = {2023},
  volume = {11},
  doi = {10.3389/fped.2023.1050706}
}
Kostenlos starten →